ORKA — ORUKA THERAPEUTICS INC

Ownership history in B Group, Inc. · 5 quarters on record

This page tracks every 13F SEC filing in which B Group, Inc. reported a position in ORUKA THERAPEUTICS INC (ORKA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

1.68% (2025 Q4)

Avg. % of fund

0.83%

First filed

2024 Q4

Last filed

2025 Q4

Quarters held

5

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q4	UNCHANGED	75,000	—	0%	1.68%	$2.3M	$30.31
2025 Q3	UNCHANGED	75,000	—	0%	1.06%	$1.4M	$19.23
2025 Q2	ADDED	75,000	+16,785	+28.8%	0.65%	$841K	$11.21
2025 Q1	ADDED	58,215	+38,215	+191.1%	0.51%	$597K	$10.26

% of Fund (quarterly) ORKA price (monthly, adj. close)

Other funds also holding ORKA

As of 2025 Q4 — sorted by position size

Remedium Capital Partners, LLC 27.64% Fairmount Funds Management LLC 3Y 8.55% VR Adviser, LLC 3Y 6.21% Avidity Partners Management LP 3Y 5.77% Commodore Capital LP 3Y 3.54% SR ONE CAPITAL MANAGEMENT, LP 3Y 1.85% GREAT POINT PARTNERS LLC 3Y 7Y 1.8% Synergy Asset Management, LLC 3Y 1.45% Affinity Asset Advisors, LLC 3Y 1.39% Paradigm Biocapital Advisors LP 3Y 1.32%

← Back to B Group, Inc. Holdings